4//SEC Filing
Goel Shubh 4
Accession 0001104659-21-151823
CIK 0001211583other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 5:49 PM ET
Size
8.1 KB
Accession
0001104659-21-151823
Insider Transaction Report
Form 4
Goel Shubh
Chief Commercial Officer
Transactions
- Award
Restricted Share Unit (right to receive value of a share)
2021-12-20+37,500→ 37,500 totalExercise: $0.00Exp: 2031-12-20→ Common Shares (37,500 underlying) - Award
Stock Option (right to buy)
2021-12-20+75,000→ 75,000 totalExercise: $4.08Exp: 2031-12-20→ Common Shares (75,000 underlying)
Footnotes (3)
- [F1]On December 20, 2021, Shubh Goel was granted an incentive stock option to purchase 75,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
- [F2]On December 20, 2021, Shubh Goel was granted restricted share units to receive 37,500 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
- [F3]Item vests 100% upon FDA approval of PEDMARKTM.
Documents
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
Related Parties
1- filerCIK 0001787942
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 5:49 PM ET
- Size
- 8.1 KB